1. Home
  2. BNL vs BLLN Comparison

BNL vs BLLN Comparison

Compare BNL & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

HOLD

Current Price

$19.74

Market Cap

3.3B

Sector

Real Estate

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$78.08

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNL
BLLN
Founded
2007
2016
Country
United States
United States
Employees
N/A
713
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.5B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
BNL
BLLN
Price
$19.74
$78.08
Analyst Decision
Buy
Buy
Analyst Count
9
7
Target Price
$20.22
$126.71
AVG Volume (30 Days)
3.3M
281.7K
Earning Date
04-29-2026
03-04-2026
Dividend Yield
5.93%
N/A
EPS Growth
N/A
N/A
EPS
0.50
N/A
Revenue
$454,138,000.00
N/A
Revenue This Year
$7.99
$45.96
Revenue Next Year
$5.27
$30.11
P/E Ratio
$39.41
N/A
Revenue Growth
5.17
N/A
52 Week Low
$15.15
$61.96
52 Week High
$19.91
$138.70

Technical Indicators

Market Signals
Indicator
BNL
BLLN
Relative Strength Index (RSI) 63.64 50.17
Support Level $17.98 $64.99
Resistance Level $19.82 $83.20
Average True Range (ATR) 0.39 6.77
MACD 0.12 1.24
Stochastic Oscillator 93.14 43.51

Price Performance

Historical Comparison
BNL
BLLN

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: